Marcello Damiani
Chief Digital & Operational Excellence Officer @ Moderna
Boston, United States
Marcello Damiani is a startup investor at Moderna in Boston. Damiani has a wealth of experience in both tech companies and life science companies and a true passion for making digital a reality. He has 20 years of experience working in the IT field, with the last 10 years being spent in leadership roles for multinational companies in Europe and the United States. Prior to joining Moderna Therapeutics,Marcello has been instrumental in conceiving and building creative IT solutions to help solve business challengers, first at Motorola, then at bioMerieux, and now at Moderna Therapeutics. His expertise is in visioning, strategizing, and implementing innovative programs to update and streamline the digital landscapes. He is known for his ability to transform a company’s Information flow and ultimately improve the product and the company’s processes through digitalization. Damiani possesses a master of science degree in information systems architecture from the University of Toulouse in France, and an international Executive MBA through TRIUM, an alliance of three of the world’s top universities: the London School of Economics, New York University Stern Business School, and the HEC School of Management in Paris.
Last updated:
For AI agents: llms.txt
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
About Moderna
Moderna Therapeutics is a biotechnology company that develops messenger RNA therapeutics. Every cell in the body uses mRNA to provide real-time instructions to make the proteins necessary to drive all aspects of biology, including in human health and disease. It provides in vivo drug modality that produces human proteins or antibodies insidepatient cells. Moderna Therapeutics also develops various patent applications with various claims ranging from novel nucleotide chemistries to specific drug compositions. It focuses on disease areas, such as inherited genetic disorders, hemophilia, and blood factors, and oncology. Moderna Therapeutics in 2010 and is headquartered in Cambridge in Massachusetts. It has strategic option agreements with AstraZeneca and Alexion Pharmaceuticals and strategic collaborations with Karolinska Institutet, Institut Pasteur, Karolinska University Hospital, and Merck.
Moderna Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Eric Ma
Principal Data Scientist
|
|||
Kenneth Chien
Co-Founder
|
|||
|
Marcello Damiani
Chief Digital & Operational Excellence Officer
|
|||
John Mendlein
President, Corporate and Product Strategy
|
|||
Noubar Afeyan
Chairman & Co-Founder
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
How do I contact Marcello Damiani?
Public channels for Marcello Damiani include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
